Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 19 studies | 60% ± 23% | |
lung | 13 studies | 28% ± 11% | |
peripheral blood | 10 studies | 20% ± 6% | |
eye | 9 studies | 47% ± 24% | |
kidney | 7 studies | 28% ± 14% | |
heart | 6 studies | 43% ± 19% | |
liver | 5 studies | 38% ± 22% | |
intestine | 4 studies | 24% ± 8% | |
adipose | 4 studies | 44% ± 17% | |
lymph node | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 7723.81 | 459 / 459 | 100% | 42.46 | 1118 / 1118 |
esophagus | 100% | 6686.71 | 1445 / 1445 | 100% | 26.76 | 183 / 183 |
prostate | 100% | 9006.58 | 245 / 245 | 100% | 30.15 | 502 / 502 |
thymus | 100% | 9437.68 | 653 / 653 | 100% | 34.71 | 604 / 605 |
uterus | 100% | 9241.20 | 170 / 170 | 100% | 31.36 | 458 / 459 |
lung | 100% | 6925.81 | 578 / 578 | 100% | 25.44 | 1152 / 1155 |
brain | 100% | 7721.73 | 2640 / 2642 | 99% | 31.43 | 701 / 705 |
bladder | 100% | 7521.38 | 21 / 21 | 99% | 24.89 | 500 / 504 |
pancreas | 100% | 3816.06 | 327 / 328 | 99% | 24.34 | 177 / 178 |
liver | 100% | 4951.75 | 226 / 226 | 99% | 16.35 | 402 / 406 |
adrenal gland | 100% | 6777.55 | 258 / 258 | 99% | 23.67 | 227 / 230 |
kidney | 100% | 6053.82 | 89 / 89 | 98% | 24.02 | 886 / 901 |
stomach | 100% | 5385.47 | 359 / 359 | 97% | 18.59 | 277 / 286 |
ovary | 100% | 10613.34 | 180 / 180 | 97% | 14.63 | 416 / 430 |
intestine | 100% | 7602.44 | 966 / 966 | 96% | 19.14 | 508 / 527 |
skin | 100% | 6475.36 | 1809 / 1809 | 95% | 25.45 | 447 / 472 |
blood vessel | 100% | 6675.05 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.19 | 29 / 29 |
muscle | 100% | 6223.33 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8294.15 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.51 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.39 | 1 / 1 |
adipose | 100% | 7424.88 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 4950.86 | 851 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 14.31 | 62 / 80 |
peripheral blood | 71% | 2908.62 | 664 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043484 | Biological process | regulation of RNA splicing |
GO_0008380 | Biological process | RNA splicing |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | ZNF638 |
Protein name | Zinc finger protein 638 (Cutaneous T-cell lymphoma-associated antigen se33-1) (CTCL-associated antigen se33-1) (Nuclear protein 220) (Zinc finger matrin-like protein) Zinc finger protein 638 |
Synonyms | ZFML NP220 |
Description | FUNCTION: Transcription factor that binds to cytidine clusters in double-stranded DNA . Plays a key role in the silencing of unintegrated retroviral DNA: some part of the retroviral DNA formed immediately after infection remains unintegrated in the host genome and is transcriptionally repressed . Mediates transcriptional repression of unintegrated viral DNA by specifically binding to the cytidine clusters of retroviral DNA and mediating the recruitment of chromatin silencers, such as the HUSH complex, SETDB1 and the histone deacetylases HDAC1 and HDAC4 . Acts as an early regulator of adipogenesis by acting as a transcription cofactor of CEBPs (CEBPA, CEBPD and/or CEBPG), controlling the expression of PPARG and probably of other proadipogenic genes, such as SREBF1 (By similarity). May also regulate alternative splicing of target genes during adipogenesis (By similarity). . |
Accessions | ENST00000461991.3 ENST00000454122.1 ENST00000475743.1 ENST00000454278.5 ENST00000455226.5 ENST00000264447.9 [Q14966-1] A0A096LNQ0 Q14966 A0A096LPB4 A0A096LNS4 C9JMR2 C9JWN0 A0A096LNR2 ENST00000437658.2 A0A096LPI0 C9JHV0 A0A096LNX0 ENST00000410075.5 [Q14966-6] ENST00000409544.5 [Q14966-1] ENST00000466330.5 A0A096LPK8 C9JSD0 ENST00000417778.5 ENST00000493576.6 ENST00000494621.5 ENST00000464375.5 ENST00000466975.5 |